Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • Log out
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Rapid CommunicationShort Communication

Real-Time Quantitative Polymerase Chain Reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA Levels in Caco-2 Cell Lines, Human Duodenal Enterocytes, Normal Colorectal Tissues, and Colorectal Adenocarcinomas

Tsutomu Nakamura, Toshiyuki Sakaeda, Nobuko Ohmoto, Takao Tamura, Nobuo Aoyama, Toshiro Shirakawa, Takashi Kamigaki, Takeshi Nakamura, Ke Ih Kim, Soo Ryang Kim, Yoshikazu Kuroda, Masafumi Matsuo, Masato Kasuga and Katsuhiko Okumura
Drug Metabolism and Disposition January 2002, 30 (1) 4-6; DOI: https://doi.org/10.1124/dmd.30.1.4
Tsutomu Nakamura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshiyuki Sakaeda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nobuko Ohmoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takao Tamura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nobuo Aoyama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshiro Shirakawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takashi Kamigaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takeshi Nakamura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ke Ih Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Soo Ryang Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshikazu Kuroda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masafumi Matsuo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masato Kasuga
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katsuhiko Okumura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The expression levels of mRNAs for MDR1 (P-glycoprotein), multidrug resistance-associated proteins (MRP1, MRP2), and cytochrome P450 3A (CYP3A) in Caco-2 cells were quantitatively compared with those in human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas. Caco-2 cells (passages 36–88) were kindly supplied by several laboratories in Japan. Human duodenal enterocytes were obtained from five healthy male volunteers. Normal colorectal tissues and colorectal adenocarcinomas were simultaneously obtained from seven patients with primary colorectal adenocarcinoma. MDR1, MRP1, MRP2, and CYP3A mRNA levels were determined by real-time quantitative polymerase chain reactions (PCR). Relative concentrations of mRNAs for target proteins (MDR1, MRP1, MRP2, and CYP3A) and glyceraldehyde-3-phosphate dehydrogenase in Caco-2 cells were 1.00 ± 0.15, 1.02 ± 0.06, 0.94 ± 0.10, and 0.68 ±0.60, respectively, and those in human enterocytes were about 12-, 3-, 7-, and 8000-fold higher than in the Caco-2 cells, respectively. In contrast, MDR1, MRP1, and CYP3A mRNA levels in Caco-2 cells were comparable to those in normal colorectal tissue and colorectal adenocarcinoma.

Recent technological innovations in drug discovery (i.e., combinatorial chemistry and high-throughput screening for pharmacological activity) have enabled us to produce large numbers of potentially useful candidate drugs within a week, and the rapid assessment of their pharmacokinetic and toxicological properties, especially oral absorption, has become the bottleneck in drug development (Rodrigues, 1997; Fernandes, 1998; Tarbit and Berman, 1998). Over the last few decades, a correlation between intestinal epithelial cell permeability and the overall intestinal absorption has been demonstrated, and this has prompted us to use intestinal epithelial cell lines and to conduct in vitro transport studies (Boulenc, 1997). Among the large number of established cell lines, the Caco-2 cell line obtained from human colorectal cancer is the most useful for such studies since it is capable of morphological and biochemical differentiation in vitro to form intestinal epithelium under normal culture conditions (Pinto et al., 1983; Hidalgo and Li, 1996; Artursson and Borchardt, 1997; Boulenc, 1997; Watkins, 1997; Milovic et al., 1998). Caco-2 cells express several markers and drug-metabolizing enzymes, and several transporters were found in human enterocytes, including cytochrome P450 3A (CYP3A) and P-glycoprotein (MDR1), which have recently attracted a great deal of attention due to their barrier function against xenobiotics (Hidalgo and Li, 1996; Watkins, 1997). Recently, the contribution of the multidrug resistance-associated protein (MRP1) family to drug extrusion has also been demonstrated using Caco-2 cells (Hirohashi et al., 2000). Thus, the Caco-2 system has been shown to be useful for evaluation of the transport mechanism in addition (Hidalgo and Li, 1996; Artursson and Borchardt, 1997; Boulenc, 1997; Watkins, 1997). However, claims have sometimes been made concerning the essential characteristics of tumor cells (Milovic et al., 1998)—that these cells have a lower metabolic capacity than human enterocytes (Hidalgo and Li, 1996; Schmiedlin-Ren et al., 1997) and show alterations in expression levels of oral drug absorption-related proteins during culture and passage (Pinto et al., 1983; Hidalgo and Li, 1996). In this study, mRNA levels of MDR1, MRP1, MRP2, and CYP3A in Caco-2 cell lines were quantitatively compared with those in human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas by means of the real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) (Gibson et al., 1996;Heid et al., 1996).

Materials and Methods

Caco-2 Cell Lines and Cell Culture.

Caco-2 cells (passage 47) obtained from the RIKEN cell bank (RIKEN RCB0988; Saitama, Japan) were used as the authentic standard in each run of the assay since they were demonstrated to express sufficient levels of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), MDR1, MRP1, MRP2, and CYP3A mRNA. Caco-2 cells (passages 36–88) were also kindly supplied by several laboratories in Japan. Caco-2 cells were grown in complete medium consisting of Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA) containing 10% fetal bovine serum (Hyclone Laboratories, Logan, UT), 0.1 mM minimal essential medium nonessential amino acids (Invitrogen), 2 mMl-glutamine (Invitrogen), 100 U/ml penicillin, and 100 μg/ml streptomycin (Invitrogen) in an atmosphere of 95% air and 5% CO2 at 37°C (Tsuji et al., 1994). The cells were subcultured every 5 to 7 days using 0.02% EDTA and 0.05% trypsin. The assay was conducted 5 to 7 days after seeding of 1 × 105 cells in 10 ml of complete culture medium in 25-cm2 culture flasks (Nunclon flasks; Nalge Nunc International, Rochester, NY).

Human Duodenal Enterocytes, Normal Colorectal Tissues, and Colorectal Adenocarcinomas.

Duodenal enterocytes were obtained as proximal small-bowel mucosal biopsy samples from five healthy Japanese male volunteers ranging in age from 27 to 39 years old. The subjects took no medications and had no significant health problems. After fasting overnight, the mucosal biopsy samples were obtained by upper-intestinal endoscopy from each subject and were immediately snap-frozen and stored at −80°C. Colorectal adenocarcinomas were obtained as surgical samples from seven patients with primary colorectal adenocarcinoma diagnosed at Kobe University Hospital (four men and three women; age range, 70–80 years). Normal colorectal tissues were simultaneously taken from the resected bowel specimens but were from regions well away from the tumor. Normal colorectal tissue and adenocarcinoma samples were obtained immediately after resection, and they were quickly stripped of connective tissue, snap-frozen, and stored at −80°C until processing. Informed consent was obtained from all subjects before their participation in the study. The protocol was approved by the Institutional Review Broad of Kobe University Hospital (Kobe University, Japan).

RNA Extraction and RT.

Total RNA was extracted from confluent monolayers of Caco-2 cell lines and tissue samples using an RNeasy mini-kit (QUIAGEN, Hilden, Germany) and an RNase-free DNase set (QUIAGEN). The RT reaction was conducted in 20 μl of two-step RT reaction mix containing 4 μl of the extracted total RNA (2 μg/ml), 1× TaqMan RT buffer, 5.5 mM MgCl2, 500 μM dATP, 500 μM dGTP, 500 μM dCTP, 500 μM dUTP, 2.5 μM random hexamer, 0.4 U/μl of RNase inhibitor, and 1.25 U/μl MultiScribe reverse transcriptase (Applied Biosystems, Foster City, CA). The mixture was incubated at 25°C for 10 min and subsequently at 48°C for 30 min. RT reaction was terminated by heating at 95°C for 5 min, followed by cooling at 4°C for 5 min, giving the RT product.

Real-Time Quantitative PCR.

Primer pairs and TaqMan probes for MDR1, MRP1, MRP2, and CYP3A mRNA were designed using the Primer Express 1.0 program (Applied Biosystems) (Table 1). Primers and the TaqMan probe for GAPDH were purchased from Applied Biosystems (TaqMan GAPDH control reagent kit). The principle of real-time quantitative PCR has been described elsewhere (Gibson et al., 1996; Heid et al., 1996; Yajima et al., 1998; Latil et al., 2000). The 25 μl of reaction mixtures contained 1× TaqMan buffer A, 5.5 mM MgCl2, 400 μM dUTP, 200 μM dATP, 200 μM dCTP, 200 μM dGTP, 0.01 U/μl AmpErase UNG, 0.025 U/μl AmpliTaq Gold DNA polymerase, 200 nM each forward and reverse primer, 100 nM TaqMan probe (Applied Biosystems), and 1 μl of RT product. The reaction was performed in triplicate for each RT product. During the extension phase of PCR, consisting of an initial denaturation step at 95°C for 10 min, followed by 40 cycles of 95°C for 15 s, and 60°C for 1 min, the nucleolytic DNA polymerase cleaved the hybridization probe, and the resulting relative increase in the reporter fluorescent dye emission was monitored in real time using a sequence detector (ABI prism 7700 sequence detector; Applied Biosystems). The fluorescent dye emission was a function of cycle number and was determined using the sequence detector software (Applied Biosystems), giving the threshold cycle number (CT) at which PCR amplification reached a significant threshold. The value of the CT was linearly correlated with logarithmic value of genomic DNA quantity.

View this table:
  • View inline
  • View popup
Table 1

Sequences of oligonucleotide primers and probes used for real-time quantitative PCR

The PCR products obtained by this real-time quantitative PCR procedure were confirmed to be the expected products by electrophoresis through 3.0% agarose gels in the presence of ethidium bromide with visualization under UV illumination (data not shown). The PCR products for the target proteins were undetectable in the real-time PCR procedure without reverse transcription.

In each run of the assay, mRNAs of GAPDH and a target protein (i.e., MDR1, MRP1, MRP2, and CYP3A) were analyzed in 5-fold serially diluted samples from authentic Caco-2 cells (0.16, 0.8, 4, 20, 100 ng as total RNA determined spectrophotometrically). The standard lines were constructed by plotting mean CT values against quantity (the relative copy number). The mRNA levels of GAPDH and a target protein in Caco-2 cells from several laboratories and tissue samples were calculated from the mean CT values.

The mRNA levels of MDR1, MRP1, MRP2, and CYP3A are expressed as concentrations relative to GAPDH mRNA. Values are given as the means ± S.E. Statistical comparisons were performed by one-way analysis of variance followed by Sheffé's test. Pvalues of less than 0.05 (two-tailed) were considered significant.

Results and Discussion

Usually, the standard lines constructed gave good linearity with excellent correlation coefficients, with minimum day-to-day or within-a-day variation. Figure 1 shows the relative concentrations of MDR1, MRP1, MRP2, and CYP3A mRNA in Caco-2 cells, human duodenal enterocytes, normal colorectal tissue, and colorectal adenocarcinoma. The relative concentration of MDR1 mRNA in the Caco-2 cells was 1.00 ± 0.15 and was significantly lower than human duodenal enterocytes (11.89 ± 2.45) but comparable to normal colorectal tissue and colorectal adenocarcinoma (0.88 ± 0.33 and 0.60 ± 0.29, respectively). Caco-2 cells tended to have a lower level of MRP1 mRNA than human duodenal enterocytes, normal colorectal tissue, and colorectal adenocarcinoma (1.02 ± 0.06, 2.86 ± 2.36, 1.74 ± 0.76, and 1.65 ± 0.69, respectively). MRP2 mRNA level in Caco-2 cells was also lower than human duodenal enterocytes, but MRP2 mRNA was barely detectable in normal colorectal tissues and colorectal adenocarcinomas. Three of five Caco-2 cell lines had no detectable CYP3A mRNA, even after 40 cycles of PCR. CYP3A mRNA level in Caco-2 cells was extensively lower than human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas (0.68 ± 0.60, 5645.76 ± 1367.73, 27.27 ± 13.36, and 16.47 ± 8.17, respectively).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Relative concentrations of mRNAs for MDR1 (A), MRP1 (B), MRP2 (C), and CYP3A (D) in the Caco-2 cell lines, human duodenal enterocytes, and human colorectal tissues.

Relative concentrations of MDR1, MRP1, MRP2, and CYP3A mRNA were determined by real-time quantitative PCR. GAPDH was selected as an endogenous RNA control to normalize for differences in the amount of total RNA. Each bar represents the average and standard error of the respective relative concentrations. ∗, p < 0.05, significantly different from Caco-2 cells. †, p < 0.05, significantly different from colorectal tissue.

Real-time quantitative PCR method in which the amplification signals are detected in real time has advantages over ordinary semiquantitative methods based on densitometry involving a competitive PCR method and Northern analysis, which contains a lengthy series of steps (mRNA preparation, electrophoresis, blotting, hybridization, and autoradiography) (Gibson et al., 1996; Heid et al., 1996; Yajima et al., 1998; Latil et al., 2000). Besides, this method makes it possible to quickly evaluate with high sensitivity the gene expression profiles for numbers of target proteins, and therefore, it is useful as a speedy assessment in advance of a functional analysis. In this article, it was suggested that Caco-2 cells expressed only low levels of MDR1, MRP1, MRP2, and CYP3A mRNA in comparison with human duodenal enterocytes. CYP3A mRNA levels varied remarkably for Caco-2 cell lines, suggesting that its content is susceptible to culture conditions. These observations strongly suggested that considerable attention should be paid to the transport data obtained from the Caco-2 cell system in determining the overall absorption kinetics. It was also suggested that the gene expression levels of these molecules in Caco-2 cells were comparable with those in normal colorectal tissue and colorectal adenocarcinoma, except for MRP2. Collectively, Caco-2 cell lines showed the gene expression profiles of oral drug absorption-related proteins closer to those of human normal colorectal tissue and adenocarcinoma rather than human duodenal enterocytes.

Acknowledgments

We thank Dr. Ken-ichi Inui and collaborators at the Department of Pharmacy (Kyoto University Hospital, Faculty of Medicine, Kyoto University) for helpful discussions and critical comments on the draft of the manuscript. We thank Drs. Akira Tsuji and Ikumi Tamai of the Department of Pharmacobiodynamics (Faculty of Pharmaceutical Sciences, Kanazawa University), Dr. Mitsuru Hashida of the Department of Drug Delivery Research (Graduate School of Pharmaceutical Sciences, Kyoto University), Dr. Shinji Yamashita of the Department of Pharmaceutics (Faculty of Pharmaceutical Sciences, Setsunan University), Drs. Toshikiro Kimura and Kazutaka Higaki of the Department of Pharmaceutics (Faculty of Pharmaceutical Sciences, Okayama University), and Dr. S. Akira Yamamoto and Takuya Fujita of the Department of Biopharmaceutics and Biochemical Pharmacology (Kyoto Pharmaceutical University) for kindly supplying Caco-2 cells and helpful suggestions.

Footnotes

  • Abbreviations used are::
    MRP
    multidrug resistance-associated protein
    RT-PCR
    reverse transcription-polymerase chain reaction
    GAPDH
    glyceraldehyde-3-phosphate dehydrogenase
    CT
    threshold cycle number
    • Received June 25, 2001.
    • Accepted October 16, 2001.
  • The American Society for Pharmacology and Experimental Therapeutics

References

  1. ↵
    1. Artursson P,
    2. Borchardt RT
    (1997) Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond. Pharm Res 14:1655–1658.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Boulenc X
    (1997) Intestinal cell models: their use in evaluating the metabolism and absorption of xenobiotics. STP Pharm Sci 7:259–269.
  3. ↵
    1. Fernandes PB
    (1998) Technological advances in high-throughput screening. Curr Opinion Chem Biol 2:597–603.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Gibson UEM,
    2. Heid CA,
    3. Williams PM
    (1996) A novel method for real time quantitative PT-PCR. Genome Methods 6:995–1001.
    OpenUrl
  5. ↵
    1. Heid CA,
    2. Stevens J,
    3. Livak KL,
    4. Williams PM
    (1996) Real time quantitative PCR. Genome Methods 6:986–994.
    OpenUrl
  6. ↵
    1. Hidalgo IJ,
    2. Li J
    (1996) Carrier-mediated transport and efflux mechanisms in Caco-2 cells. Adv Drug Delivery Rev 22:53–66.
  7. ↵
    1. Hirohashi T,
    2. Suzuki H,
    3. Chu X-Y,
    4. Tamai I,
    5. Tsuji A,
    6. Sugiyama Y
    (2000) Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). J Pharmacol Exp Ther 292:265–270.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Latil A,
    2. Vidaud D,
    3. Valéri A,
    4. Fournier G,
    5. Vidaud M,
    6. Lidereau R,
    7. Cussenot O,
    8. Bieche I
    (2000) htert expression correlates with MYC over-expression in human prostate cancer. Int J Cancer 89:172–176.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Milovic V,
    2. Ocklind G,
    3. Artursson P
    (1998) Conditionally immortalized intestinal epithelial cells. Ann N Y Acad Sci 859:201–203.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Pinto M,
    2. Robine-Leon S,
    3. Appay MD,
    4. Kedinger M,
    5. Triadou N,
    6. Dussaulx E,
    7. Lacroix B,
    8. Simon-Assmann P,
    9. Haffen K,
    10. Fogh J,
    11. Zweibaum A
    (1983) Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol Cell 47:323–330.
    OpenUrl
  11. ↵
    1. Rodrigues AD
    (1997) Preclinical drug metabolism in the age of high-throughput screening: an industrial perspective. Pharm Res 14:1504–1510.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Schmiedlin-Ren P,
    2. Thummel KE,
    3. Fisher JM,
    4. Paine MF,
    5. Lown KS,
    6. Watkins PB
    (1997) Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1α,25-dihydroxyvitamin D3. Mol Pharmacol 51:741–754.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Tarbit MH,
    2. Berman J
    (1998) High-throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compounds. Curr Opinion Chem Biol 2:411–415.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Tsuji A,
    2. Takanaga H,
    3. Tamai I,
    4. Terasaki T
    (1994) Transcellular transport of benzoic acid across Caco-2 cells by a pH-dependent and carrier-mediated transport mechanism. Pharm Res 11:30–37.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Watkins PB
    (1997) The barrier function of CYP3A4 and P-glycoprotein in the small bowel. Adv Drug Delivery Rev 27:161–170.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Yajima T,
    2. Yagihashi A,
    3. Kameshima H,
    4. Kobayashi D,
    5. Furuya D,
    6. Hirata K,
    7. Watanabe N
    (1998) Quantitative reverse transcription-PCR assay of the RNA component of human telomerase using the TaqMan fluorogenic detection system. Clin Chem 44:2441–2445.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 30 (1)
Drug Metabolism and Disposition
Vol. 30, Issue 1
1 Jan 2002
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Real-Time Quantitative Polymerase Chain Reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA Levels in Caco-2 Cell Lines, Human Duodenal Enterocytes, Normal Colorectal Tissues, and Colorectal Adenocarcinomas
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rapid CommunicationShort Communication

Real-Time Quantitative Polymerase Chain Reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA Levels in Caco-2 Cell Lines, Human Duodenal Enterocytes, Normal Colorectal Tissues, and Colorectal Adenocarcinomas

Tsutomu Nakamura, Toshiyuki Sakaeda, Nobuko Ohmoto, Takao Tamura, Nobuo Aoyama, Toshiro Shirakawa, Takashi Kamigaki, Takeshi Nakamura, Ke Ih Kim, Soo Ryang Kim, Yoshikazu Kuroda, Masafumi Matsuo, Masato Kasuga and Katsuhiko Okumura
Drug Metabolism and Disposition January 1, 2002, 30 (1) 4-6; DOI: https://doi.org/10.1124/dmd.30.1.4

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Rapid CommunicationShort Communication

Real-Time Quantitative Polymerase Chain Reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA Levels in Caco-2 Cell Lines, Human Duodenal Enterocytes, Normal Colorectal Tissues, and Colorectal Adenocarcinomas

Tsutomu Nakamura, Toshiyuki Sakaeda, Nobuko Ohmoto, Takao Tamura, Nobuo Aoyama, Toshiro Shirakawa, Takashi Kamigaki, Takeshi Nakamura, Ke Ih Kim, Soo Ryang Kim, Yoshikazu Kuroda, Masafumi Matsuo, Masato Kasuga and Katsuhiko Okumura
Drug Metabolism and Disposition January 1, 2002, 30 (1) 4-6; DOI: https://doi.org/10.1124/dmd.30.1.4
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Preincubation Effects on Inhibition of OCT1 by CsA
  • Carbamazepine Metabolite and Hypersensitivity Reactions
  • SULT4A1 Preserves Mitochondrial Function
Show more Short Communication

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics